Sort   by:  
 Page size 
UnknownRandomized Trial of Lenalidomide Alone Versus Lenalidomide Plus Rituximab in Patients With Recurrent Follicular Lymphoma: CALGB 50401 (Alliance).
Not available
S-EPMC4622102 | biostudies-literature
UnknownActive idiotypic vaccination versus control immunotherapy for follicular lymphoma.
Not available
S-EPMC4039868 | biostudies-literature
UnknownTreatment Selection and Prioritization for the EJS ACT-PD MAMS Trial Platform.
Not available
S-EPMC12273612 | biostudies-literature
UnknownUS Intergroup Trial of Response-Adapted Therapy for Stage III to IV Hodgkin Lymphoma Using Early Interim Fluorodeoxyglucose-Positron Emission Tomography Imaging: Southwest Oncology Group S0816.
Not available
S-EPMC4966513 | biostudies-literature
UnknownCDX1 is an important molecular mediator of Barrett's metaplasia.
Not available
S-EPMC1140438 | biostudies-literature
UnknownSevere asthma ILC2s demonstrate enhanced proliferation that is modified by biologics.
Not available
S-EPMC10946917 | biostudies-literature
UnknownPatient-reported outcomes in RA care improve patient communication, decision-making, satisfaction and confidence: qualitative results.
Not available
S-EPMC7310086 | biostudies-literature
UnknownThe relationship between lifestyle and serum neurofilament light protein in Huntington's disease.
Not available
S-EPMC7218250 | biostudies-literature
UnknownTLE3 is not a predictive biomarker for taxane sensitivity in the NCIC CTG MA.21 clinical trial.
Not available
S-EPMC4559832 | biostudies-literature
UnknownTowards a multi-arm multi-stage platform trial of disease modifying approaches in Parkinson's disease.
Not available
S-EPMC10316775 | biostudies-literature
Sort   by:  
 Page size